Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 24Arthralgia 5Neoplasm Metastasis 3Patient Compliance 2Obesity 2Neoplasms 2Advanced Breast Cancer 2Vitamin D Deficiency 1Recurrence 1Pain 1Osteoporosis 1Nutrition Disorders 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fractures, Bone 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Cancer Organoids 1Arthritis 1

Interventions

Letrozole 2Anastrozole 2trastuzumab deruxtecan 1dalpiciclib 1Vinorelbine 1Standard of Care 1Safety 1Radiotherapy 1In Situ Hybridization, Fluorescence 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Advanced Breast Cancer × Anastrozole × Clear all
NCT07225790 2026-05-12

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
3,883 enrolled
Breast

Advanced Breast Cancer

NCT00562458 2013-02-05

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

AstraZeneca

Completed
200 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡